| Bioactivity | ASN-001 is an orally active CYP-17A1 lyase inhibitor that selectively inhibits testosterone synthesis. ASN-001 has anticancer activity and can be used for research in the field of prostate cancer[1]. |
| CAS | 1429329-63-4 |
| Formula | C16H13FN2OS |
| Molar Mass | 300.35 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Barata P, et al. Treatment selection for men with metastatic prostate cancer who progress on upfront chemo-hormonal therapy. Prostate. 2018 Sep;78(13):1035-1041. |
ASN-001
CAS: 1429329-63-4 F: C16H13FN2OS W: 300.35
ASN-001 is an orally active CYP-17A1 lyase inhibitor that selectively inhibits testosterone synthesis. ASN-001 has antic
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.